220 related articles for article (PubMed ID: 6086700)
21. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
22. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
Castro M; Moreira AC
Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
[TBL] [Abstract][Full Text] [Related]
23. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
[TBL] [Abstract][Full Text] [Related]
24. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive corticotropin-releasing hormone present in human plasma may be derived from both hypothalamic and extrahypothalamic sources.
Sasaki A; Sato S; Murakami O; Go M; Inoue M; Shimizu Y; Hanew K; Andoh N; Sato I; Sasano N
J Clin Endocrinol Metab; 1987 Jul; 65(1):176-82. PubMed ID: 3294879
[TBL] [Abstract][Full Text] [Related]
26. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
[TBL] [Abstract][Full Text] [Related]
27. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
[TBL] [Abstract][Full Text] [Related]
28. Urinary molecular forms of human N-terminal of proopiomelanocortin: possible deglycosylation and degradation by the kidney.
Gaspar L; Chan JS; Seidah NG; Chrétien M
J Clin Endocrinol Metab; 1984 Oct; 59(4):614-21. PubMed ID: 6480799
[TBL] [Abstract][Full Text] [Related]
29. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
Reincke M; Allolio B; Würth G; Winkelmann W
J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
[TBL] [Abstract][Full Text] [Related]
30. Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.
Hope J; Ratter SJ; Estivariz FE; McLoughlin L; Lowry PJ
Clin Endocrinol (Oxf); 1981 Sep; 15(3):221-7. PubMed ID: 6273026
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness of hypophyseal-adrenocortical axis to repetitive administration of synthetic ovine corticotropin-releasing hormone in patients with isolated adrenocorticotropin deficiency.
Koide Y; Kimura S; Inoue S; Ikeda M; Uchida K; Ando J; Shimizu A; Oda K; Itakura M; Nabeshima I
J Clin Endocrinol Metab; 1986 Aug; 63(2):329-35. PubMed ID: 3013917
[TBL] [Abstract][Full Text] [Related]
32. Effect of synthetic ovine corticotropin-releasing factor: prolonged duration of action and biphasic response of plasma adrenocorticotropin and cortisol.
DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Alexander AN; Island DP; Rivier J; Vale W; Orth DN
J Clin Endocrinol Metab; 1983 Aug; 57(2):294-8. PubMed ID: 6306038
[TBL] [Abstract][Full Text] [Related]
33. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests.
Orth DN; Holscher MA; Wilson MG; Nicholson WE; Plue RE; Mount CD
Endocrinology; 1982 Apr; 110(4):1430-41. PubMed ID: 6277607
[No Abstract] [Full Text] [Related]
34. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice.
Fukuda Y; Kageyama K; Nigawara T; Kasagi Y; Suda T
Neurosci Lett; 2004 Sep; 367(2):201-4. PubMed ID: 15331153
[TBL] [Abstract][Full Text] [Related]
35. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients.
Hotta M; Shibasaki T; Masuda A; Imaki T; Demura H; Ling N; Shizume K
J Clin Endocrinol Metab; 1986 Feb; 62(2):319-24. PubMed ID: 3001125
[TBL] [Abstract][Full Text] [Related]
36. Clinical studies with synthetic ovine corticotropin-releasing factor.
Orth DN; DeBold CR; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Uderman H; Alexander AN; Island DP; Rivier J
Fed Proc; 1985 Jan; 44(1 Pt 2):197-202. PubMed ID: 2981741
[TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
[TBL] [Abstract][Full Text] [Related]
38. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Willemse T; Mol JA
Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
[TBL] [Abstract][Full Text] [Related]
39. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
[TBL] [Abstract][Full Text] [Related]
40. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
